Neuroscience research articles are provided.
What is neuroscience? Neuroscience is the scientific study of nervous systems. Neuroscience can involve research from many branches of science including those involving neurology, brain science, neurobiology, psychology, computer science, artificial intelligence, statistics, prosthetics, neuroimaging, engineering, medicine, physics, mathematics, pharmacology, electrophysiology, biology, robotics and technology.
– These articles focus mainly on neurology research. – What is neurology? – Definition of neurology: a science involved in the study of the nervous systems, especially of the diseases and disorders affecting them. – Neurology research can include information involving brain research, neurological disorders, medicine, brain cancer, peripheral nervous systems, central nervous systems, nerve damage, brain tumors, seizures, neurosurgery, electrophysiology, BMI, brain injuries, paralysis and spinal cord treatments.
What is Psychology? Definition of Psychology: Psychology is the study of behavior in an individual, or group. Psychology news articles are listed below.
Artificial Intelligence articles involve programming, neural engineering, artificial neural networks, artificial life, a-life, floyds, boids, emergence, machine learning, neuralbots, neuralrobotics, computational neuroscience and more involving A.I. research.
Robotics articles will cover robotics research press releases. Robotics news from universities, labs, researchers, engineers, students, high schools, conventions, competitions and more are posted and welcome.
Genetics articles related to neuroscience research will be listed here.
Neurotechnology research articles deal with robotics, AI, deep learning, machine learning, Brain Computer Interfaces, neuroprosthetics, neural implants and more. Read the latest neurotech news articles below.
Summary: Researchers have created the most detailed 3D structure to date of the brain receptor that binds and responds to the root of the marijuana high.
Source: UT Southwestern.
Researchers at UT Southwestern Medical Center report the most detailed 3-D structure to date of the brain receptor that binds and responds to the chemical at the root of marijuana’s high.
Their high-resolution structure of the human cannabinoid receptor 1 (CB1) and its binding site for the chemical tetrahydrocannabinol (THC) should lead to a better understanding of how marijuana affects the brain. The research also could aid discovery of new treatments for conditions that target the receptor, said Dr. Daniel Rosenbaum, Assistant Professor of Biophysics and Biochemistry at UT Southwestern.
“What is most exciting from a therapeutic standpoint is that the same receptor pocket that binds THC also binds cannabinoid inhibitors that have been studied as possible treatments for conditions such as obesity,” said Dr. Rosenbaum, senior author of the study published online today by Nature.
“The structure is an important step toward explaining how cannabinoids initiate signals in the brain that affect the release of neurotransmitters that relay messages between the brain’s neurons,” Dr. Rosenbaum said. “This 3-D structure provides high-resolution details of the binding pocket in the CB1 receptor, where plant cannabinoids like THC, cannabinoids made in the body, and synthetic cannabinoid inhibitors all work to modulate receptor function and physiology.”
He said the CB1 receptor is the target for cannabinoid inhibitor drugs now under study as possible treatments for epilepsy, pain control, obesity, and other conditions.
In a competing study released last month by the journal Cell, a U.S.-Chinese team of researchers reported a 3-D structure of the CB1 receptor at a resolution of 2.8 angstroms. The UT Southwestern study reports a higher resolution of 2.6 angstroms. (One angstrom is equivalent to one hundred-millionth of a centimeter.) The higher the resolution, the finer the details of the relationship between atoms of the protein.
“The resolution is very important. Our structure shows a different and better resolved structure at the important binding pocket that is of interest to scientists involved in drug development,” Dr. Rosenbaum said. “Overall, these two structures are complementary, but we believe our structure may provide a better framework for understanding how cannabinoids and inhibitors bind to the receptor.”
The Cell study examined the CB1 receptor bound to a synthetic chemical created to stabilize the receptor. In contrast, the UT Southwestern research team successfully imaged the receptor bound to the drug taranabant, which was tested as a possible anti-obesity treatment in clinical trials. Those trials ended due to side effects such as anxiety and depression, Dr. Rosenbaum said.
CB1 and the related CB2, which still lacks a high-resolution structural solution, are both members of the human G protein-coupled receptor family. Members of that receptor family control signaling pathways involving hormones, neurotransmitters, and sensory stimuli such as light and odors.
The team’s success depended on overcoming the receptor protein’s resistance to crystallization, which is required for the diffraction measurements used in X-ray crystallography. The researchers also conducted computer simulations of how THC might bind to the CB1 receptor, he said.
The next step is to obtain structures of CB1 actually bound to THC, he said.
Dr. Rosenbaum, a Eugene McDermott Scholar in Medical Research at UT Southwestern, was listed as one of the world’s most highly cited researchers in 2014, according to data compiled by Thomson Reuters. This is his second study published in Nature in the past six months. His earlier study pertained to the structural biology of an important membrane protein involved in cholesterol metabolism.
[divider]About this neuroscience research article[/divider]
UT Southwestern co-authors in Biophysics include lead author Dr. Zhenhua Shao and Dr. Jie Yin, postdoctoral researchers; Karen Chapman, research scientist; Magdalena Grzemska, a visiting junior researcher; and Lindsay Clark, graduate student. Dr. Junmei Wang, Associate Professor in the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology, and of Biophysics also assisted.
Funding: The research was funded by the Welch Foundation and the Packard Foundation. The study also received support from the Advanced Photon Source (APS), a U.S. Department of Energy Office of Science User Facility operated by the Argonne National Laboratory.
Source: Deborah Wormser – UT Southwestern Image Source: NeuroscienceNews.com image is credited to UT Southwestern Medical Center. Original Research: Abstract for “High-resolution crystal structure of the human CB1 cannabinoid receptor” by Zhenhua Shao, Jie Yin, Karen Chapman, Magdalena Grzemska, Lindsay Clark, Junmei Wang and Daniel M. Rosenbaum in Nature. Published online November 16 2016 doi:10.1038/nature20613
[divider]Cite This NeuroscienceNews.com Article[/divider]
[cbtabs][cbtab title=”MLA”]UT Southwestern. “Highest Resolution Model of Brain Receptor Behind Marijuana’s High Created.” NeuroscienceNews. NeuroscienceNews, 16 November 2016. <https://neurosciencenews.com/cb1-high-resolution-model-5539/>.[/cbtab][cbtab title=”APA”]UT Southwestern. (2016, November 16). Highest Resolution Model of Brain Receptor Behind Marijuana’s High Created. NeuroscienceNews. Retrieved November 16, 2016 from https://neurosciencenews.com/cb1-high-resolution-model-5539/[/cbtab][cbtab title=”Chicago”]UT Southwestern. “Highest Resolution Model of Brain Receptor Behind Marijuana’s High Created.” https://neurosciencenews.com/cb1-high-resolution-model-5539/ (accessed November 16, 2016).[/cbtab][/cbtabs]
High-resolution crystal structure of the human CB1 cannabinoid receptor
The human cannabinoid G-protein-coupled receptors (GPCRs) CB1 and CB2 mediate the functional responses to the endocannabinoids anandamide and 2-arachidonyl glycerol (2-AG), as well as the widely consumed plant (phyto)cannabinoid Δ9-tetrahydrocannabinol (THC)1. The cannabinoid receptors have been the targets of intensive drug discovery efforts owing to the therapeutic potential of modulators for controlling pain2, epilepsy3, obesity4, and other maladies. Although much progress has recently been made in understanding the biophysical properties of GPCRs, investigations of the molecular mechanisms of the cannabinoids and their receptors have lacked high-resolution structural data. We used GPCR engineering and lipidic cubic phase (LCP) crystallization to determine the structure of the human CB1 receptor bound to the inhibitor taranabant at 2.6 Å resolution. The extracellular surface of CB1, including the highly conserved membrane-proximal amino-terminal (N-terminal) region, is distinct from other lipid-activated GPCRs and forms a critical part of the ligand binding pocket. Docking studies further demonstrate how this same pocket may accommodate the cannabinoid agonist THC. Our CB1 structure provides an atomic framework for studying cannabinoid receptor function, and will aid the design and optimization of cannabinoid system modulators for therapeutic ends.
“High-resolution crystal structure of the human CB1 cannabinoid receptor” by Zhenhua Shao, Jie Yin, Karen Chapman, Magdalena Grzemska, Lindsay Clark, Junmei Wang and Daniel M. Rosenbaum in Nature. Published online November 16 2016 doi:10.1038/nature20613
[divider]Feel free to share this Neuroscience News.[/divider]